SEC Form 4 · accession 0001104659-18-038718
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhi Yang
Director
Period of report
Mar 12, 2018
Accepted (ET)
Jun 6, 2018 · 9:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2,F3,F4 | $8.40 | Mar 12, 2018 | A | 12,965 | A | — | Aug 2, 2027 | Common Stock | 12,965 | 12,965 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan
- F2All share numbers and the exercise price reflect the 1-for-15 reverse stock split effected on June 1, 2018.
- F3The option grant was approved by the Issuer's board of directors on August 2, 2017, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on March 12, 2018.
- F4Vests in equal monthly installments, beginning August 2, 2017, such that it is vested in full on the 3-year anniversary of the grant date.